Crossmark

Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2025.100651

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kumar, Shubham https://orcid.org/0009-0000-7690-950X
Mehta, Rachana

Sah, Ranjana
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-04-04
More Information

This article is maintained by: Elsevier

Article Title: Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2025.100651

Content Type: simple-article

Copyright: © 2025 HCFMUSP. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below